as 07-26-2024 4:00pm EST
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | PLYMOUTH MEETING |
Market Cap: | 1.4B | IPO Year: | N/A |
Target Price: | $11.30 | AVG Volume (30 days): | 865.6K |
Analyst Decision: | Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -5.30 | EPS Growth: | N/A |
52 Week Low/High: | $6.37 - $15.37 | Next Earning Date: | 08-06-2024 |
Revenue: | $3,248,048,000 | Revenue Growth: | 7.94% |
Revenue Growth (this year): | 5.62% | Revenue Growth (next year): | 5.71% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Flynn James E | AHCO | 10% Owner | Mar 8 '24 | Sell | $10.92 | 47,992 | $524,072.64 | 11,830,871 | SEC Form 4 |
Flynn James E | AHCO | 10% Owner | Mar 8 '24 | Sell | $11.03 | 4,495 | $49,579.85 | 11,826,376 | SEC Form 4 |
Flynn James E | AHCO | 10% Owner | Mar 8 '24 | Sell | $10.92 | 94,567 | $1,032,671.64 | 11,731,809 | SEC Form 4 |
Flynn James E | AHCO | 10% Owner | Mar 8 '24 | Sell | $11.13 | 88,040 | $979,885.20 | 11,643,769 | SEC Form 4 |
Flynn James E | AHCO | 10% Owner | Mar 8 '24 | Sell | $10.70 | 114,906 | $1,229,494.20 | 11,528,863 | SEC Form 4 |
Williams David Solomon III | AHCO | Director | Dec 4 '23 | Sell | $9.30 | 2,255 | $20,971.50 | 29,779 | SEC Form 4 |
AHCO Breaking Stock News: Dive into AHCO Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
Argus Research
10 days ago
Business Wire
11 days ago
Zacks
14 days ago
Argus Research
17 days ago
Zacks
17 days ago
Simply Wall St.
22 days ago
MT Newswires
24 days ago
The information presented on this page, "AHCO AdaptHealth Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.